{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:40:14Z","timestamp":1769924414408,"version":"3.49.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.nmd.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T03:20:07Z","timestamp":1628824807000},"page":"1266-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Models for IGHMBP2-associated diseases: an overview and a roadmap for the future"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2649-6468","authenticated-orcid":false,"given":"Weronika","family":"Rzepnikowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Kocha\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.nmd.2021.08.001_bib0002","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2021.08.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice","volume":"8","author":"Tasfaout","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2021.08.001_bib0004","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1073\/pnas.1808170115","article-title":"Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy","volume":"115","author":"Buono","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/302636","article-title":"Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21 [2]","volume":"65","author":"Grohmann","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0006","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.10755","article-title":"Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"54","author":"Grohmann","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pediatrneurol.2005.10.022","article-title":"Mutation of gene in spinal muscular atrophy respiratory distress type I","volume":"34","author":"Wong","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0008","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1542\/peds.2011-0544","article-title":"The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"129","author":"Eckart","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2021.08.001_bib0009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2014.10.002","article-title":"Truncating and missense mutations in IGHMBP2 cause charcot-marie tooth disease type 2","volume":"95","author":"Cottenie","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nmd.2016.11.008","article-title":"IGHMBP2 -related clinical and genetic features in a cohort of Chinese Charcot\u2013Marie\u2013Tooth disease type 2 patients","volume":"27","author":"Liu","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1542\/peds.53.1.33","article-title":"Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease","volume":"53","author":"Mellins","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2021.08.001_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng703","article-title":"Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1","volume":"29","author":"Grohmann","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0013","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0000000000001220","article-title":"Recessive truncating IGHMBP2 mutations presenting as axonal sensorimotor neuropathy","volume":"84","author":"Schottmann","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.08.001_bib0014","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejpn.2013.11.006","article-title":"Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells","volume":"18","author":"J\u0229drzejowska","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/0883073812453321","article-title":"Catastrophic autonomic crisis with cardiovascular collapse in spinal muscular atrophy with respiratory distress type 1","volume":"28","author":"Nomura","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0016","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.nmd.2018.08.010","article-title":"IGHMBP2 mutation associated with organ-specific autonomic dysfunction","volume":"28","author":"Tomaselli","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0017","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.nmd.2018.09.008","article-title":"Charcot Marie Tooth disease type 2S with late onset diaphragmatic weakness: an atypical case","volume":"28","author":"Kulshrestha","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0018","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nmd.2016.06.457","article-title":"Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2","volume":"26","author":"Pedurupillay","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-008-0402-7","article-title":"Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease","volume":"87","author":"Guenther","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.nmd.2021.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0896-6273(00)80652-2","article-title":"Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele","volume":"21","author":"Cox","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2021.08.001_bib0021","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.1016\/S0021-9258(19)85357-7","article-title":"The human S\u03bcbp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin \u03bc chain switch region","volume":"268","author":"Fukita","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.08.001_bib0022","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1073\/pnas.94.15.7831","article-title":"Association of the mammalian helicase MAH with the pre-mRNA splicing complex","volume":"94","author":"Molnar","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0023","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/hmg\/ddp028","article-title":"IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)","volume":"18","author":"Guenther","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.sbi.2010.03.011","article-title":"SF1 and SF2 helicases: family matters","volume":"20","author":"Fairman-Williams","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/S367","article-title":"Superfamily 1 helicases","volume":"5","author":"Gilhooly","year":"2013","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.nmd.2021.08.001_bib0026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-2836(02)01381-5","article-title":"Solution structure of the R3H domain from human S\u03bcbp-2","volume":"326","author":"Liepinsh","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0027","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1093\/nar\/gks792","article-title":"The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1","volume":"40","author":"Lim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2021.08.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06313-y","article-title":"UPF1-like helicase grip on nucleic acids dictates processivity","volume":"9","author":"Kanaan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2021.08.001_bib0029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmb.2012.09.010","article-title":"Structural basis for 5\u2032-end-specific recognition of single-stranded DNA by the R3H domain from human S\u03bcbp-2","volume":"424","author":"Jaudzems","year":"2012","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0030","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/nar\/21.8.1761","article-title":"Isolation of cDNA encoding a binding protein specific to 5\u2019-phosphorylated single-stranded DNA with G-rich sequences","volume":"21","author":"Mizuta","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2021.08.001_bib0031","doi-asserted-by":"crossref","first-page":"15876","DOI":"10.1016\/S0021-9258(18)98490-5","article-title":"A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV","volume":"266","author":"Kerr","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.08.001_bib0032","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1073\/pnas.94.15.7831","article-title":"Association of the mammalian helicase MAH with the pre-mRNA splicing complex","volume":"94","author":"Molnar","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0033","doi-asserted-by":"crossref","first-page":"21503","DOI":"10.1074\/jbc.270.37.21503","article-title":"Molecular characterization of the rat insulin enhancer-binding complex 3b2: cloning of a binding factor with putative helicase motifs","volume":"270","author":"Shieh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.08.001_bib0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-1119(96)00630-0","article-title":"Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S\u03bcbp-2 protein in glial cells","volume":"185","author":"Chen","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.nmd.2021.08.001_bib0035","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1046\/j.1432-1327.2000.01836.x","article-title":"The rat ortholog of the presumptive flounder antifreeze enhancer-binding protein is a helicase domain-containing protein","volume":"267","author":"Miao","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nmd.2021.08.001_bib0036","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/viro.1998.9588","article-title":"S\u03bcbp-2 represses the Epstein-Barr virus lytic switch promoter","volume":"255","author":"Zhang","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.nmd.2021.08.001_bib0037","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddh222","article-title":"Characterization of lghmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"13","author":"Grohmann","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0038","first-page":"1","article-title":"Disease mechanisms in spinal muscular atrophy with respiratory distress type 1 (SMARD1): what about motoneurons?","volume":"6","author":"Surrey","year":"2018","journal-title":"Med Res Arch"},{"key":"10.1016\/j.nmd.2021.08.001_bib0039","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","article-title":"Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery","volume":"18","author":"De Planell-Saguer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0040","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","article-title":"Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery","volume":"18","author":"de Planell-Saguer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0041","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2018.06.019","article-title":"Impaired local translation of \u03b2-actin mRNA in Ighmbp2-deficient motoneurons: implications for spinal muscular atrophy with respiratory distress (SMARD1)","volume":"386","author":"Surrey","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.nmd.2021.08.001_bib0042","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/jcmm.14874","article-title":"Spinal muscular atrophy with respiratory distress type 1: clinical phenotypes, molecular pathogenesis and therapeutic insights","volume":"24","author":"Saladini","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nmd.2021.08.001_bib0043","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/jcmm.12606","article-title":"Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1","volume":"19","author":"Vanoli","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nmd.2021.08.001_bib0044","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-020-03492-0","article-title":"Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)","author":"Perego","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nmd.2021.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/brain\/awu059","article-title":"Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1","volume":"137","author":"Krieger","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.08.001_bib0046","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/hmg\/ddi189","article-title":"Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice","volume":"14","author":"Ruiz","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.1500078","article-title":"Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model","volume":"1","author":"Nizzardo","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.nmd.2021.08.001_bib0048","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/mt.2016.33","article-title":"Rescue of a mouse model of spinal muscular atrophy with respiratory distress type 1 by AAV9-IGHMBP2 is dose dependent","volume":"24","author":"Shababi","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2021.08.001_bib0049","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.omtm.2018.08.005","article-title":"A direct comparison of IV and ICV delivery methods for gene replacement therapy in a mouse model of SMARD1","volume":"10","author":"Shababi","year":"2018","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"10.1016\/j.nmd.2021.08.001_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddx434","article-title":"Selective vulnerability in neuronal populations in nmd\/SMARD1 mice","volume":"27","author":"Villal\u00f3n","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0051","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/hmg\/ddi446","article-title":"Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1","volume":"15","author":"Corti","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0052","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.stemcr.2014.06.004","article-title":"iPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1","volume":"3","author":"Simone","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.nmd.2021.08.001_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113041","article-title":"CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1","volume":"321","author":"Forotti","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0054","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10522-016-9666-4","article-title":"Exploring the power of yeast to model aging and age-related neurodegenerative disorders","volume":"18","author":"Oliveira","year":"2017","journal-title":"Biogerontology"},{"key":"10.1016\/j.nmd.2021.08.001_bib0055","article-title":"Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis","volume":"12","author":"Soczewka","year":"2019","journal-title":"DMM Dis Model Mech"},{"key":"10.1016\/j.nmd.2021.08.001_bib0056","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/genes11030310","article-title":"Pathogenic effect of GDAP1 gene mutations in a yeast model","volume":"11","author":"Rzepnikowska","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.nmd.2021.08.001_bib0057","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.3390\/ijms21124277","article-title":"A yeast-based model for hereditary motor and sensory neuropathies: a simple system for complex, heterogeneous diseases","volume":"21","author":"Rzepnikowska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2021.08.001_bib0058","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1073\/pnas.1101478108","article-title":"A yeast-based assay identifies drugs active against human mitochondrial disorders","volume":"108","author":"Couplan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0059","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1101\/gr.211649.116","article-title":"Yeast genetic interaction screen of human genes associated with amyotrophic lateral sclerosis: identification of MAP2K5 kinase as a potential drug target","volume":"27","author":"Jo","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/j.nmd.2021.08.001_bib0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/genes11070828","article-title":"Flavonoids as potential drugs for VPS13-dependent rare neurodegenerative diseases","volume":"11","author":"Soczewka","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.nmd.2021.08.001_bib0061","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/ijms22020914","article-title":"Mutations in GDAP1 influence structure and function of the trans-golgi network","volume":"22","author":"Bini\u0119da","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2021.08.001_bib0062","doi-asserted-by":"crossref","first-page":"13277","DOI":"10.1021\/bi971292s","article-title":"Yeast DNA helicase A: cloning, expression, purification, and enzymatic characterization","volume":"36","author":"Biswas","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.nmd.2021.08.001_bib0063","doi-asserted-by":"crossref","first-page":"13270","DOI":"10.1021\/bi9712910","article-title":"Purification and characterization of DNA polymerase \u03b1-associated replication protein A-dependent yeast DNA helicase A","volume":"36","author":"Biswas","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.nmd.2021.08.001_sbref0064","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.0.CO;2-3","article-title":"Systematic identification, classification, and characterization of the open reading frames which encode novel helicase-related proteins in Saccharomyces cerevisiae by gene disruption and Northern analysis","volume":"15","author":"Shiratori","year":"1999","journal-title":"Yeast"},{"key":"10.1016\/j.nmd.2021.08.001_bib0065","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2021.08.001_bib0066","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1021\/bi00212a003","article-title":"DNA helicase associated with DNA polymerase \u03b1: isolation by a modified immunoaffinity chromatography","volume":"32","author":"Biswas","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.nmd.2021.08.001_bib0067","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","article-title":"Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy","volume":"100","author":"Kraemer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0068","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.152161099","article-title":"The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans","volume":"99","author":"Morley","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0069","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-7471-9_4","article-title":"What can we learn about human disease from the nematode C. Elegans?","volume":"1706","author":"Apfeld","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/biot.201000183","article-title":"Modeling human diseases in Caenorhabditis elegans","volume":"5","author":"Markaki","year":"2010","journal-title":"Biotechnol J"},{"key":"10.1016\/j.nmd.2021.08.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000027","article-title":"elegans model identifies genetic modifiers of \u03b1-synuclein inclusion formation during aging","volume":"4","author":"Van Ham","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0072","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature07274","article-title":"Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6\/7","volume":"455","author":"Fischer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.08.001_bib0073","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1101\/gad.233254.113","article-title":"Multiple small RNA pathways regulate the silencing of repeated and foreign genes in C. elegans","volume":"27","author":"Fischer","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.nmd.2021.08.001_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002369","article-title":"The ERI-6\/7 helicase acts at the first stage of an siRNA amplification pathway that targets recent gene duplications","volume":"7","author":"Fischer","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0075","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1073\/pnas.1919028117","article-title":"Caenorhabditis elegans ADAR editing and the ERI-6\/7\/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons","volume":"117","author":"Fischer","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2021.08.001_bib0076","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.csbj.2016.09.001","article-title":"Zebrafish small molecule screens: taking the phenotypic plunge","volume":"14","author":"Williams","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.nmd.2021.08.001_bib0077","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.110.003731","article-title":"Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen","volume":"123","author":"Peal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2021.08.001_bib0078","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ddtec.2012.03.001","article-title":"Zebrafish based small molecule screens for novel DMD drugs","volume":"10","author":"Kawahara","year":"2013","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0079","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-015-0555-z","article-title":"New zebrafish models of neurodegeneration","volume":"15","author":"Mart\u00edn-Jim\u00e9nez","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2021.08.001_bib0081","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/hmg\/ddz260","article-title":"Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish","volume":"28","author":"Zhao","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0082","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pneurobio.2014.03.001","article-title":"Zebrafish models of human motor neuron diseases: advantages and limitations","volume":"118","author":"Babin","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0083","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0000000000000305","article-title":"Congenital lethal motor neuron disease with a novel defect in ribosome biogenesis","volume":"82","author":"Butterfield","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.08.001_bib0084","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00293010","article-title":"Neuromuscular degeneration (nmd): a mutation on mouse Chromosome 19 that causes motor neuron degeneration","volume":"6","author":"Cook","year":"1995","journal-title":"Mamm Genome"},{"key":"10.1016\/j.nmd.2021.08.001_bib0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2012.12.010","article-title":"Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ","volume":"54","author":"Krieger","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2021.08.001_bib0086","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2019.10.032","article-title":"Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd","volume":"520","author":"Shababi","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2021.08.001_bib0087","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/hmg\/ddh129","article-title":"Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy","volume":"13","author":"Maddatu","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0088","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/hmg\/ddi349","article-title":"Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival","volume":"14","author":"Maddatu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0089","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2004-820994","article-title":"Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"35","author":"Rudnik-Sch\u00f6neborn","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2021.08.001_bib0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0091","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nmd.2021.08.001_bib0092","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jmb.2017.12.007","article-title":"A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core","volume":"430","author":"Zimmermann","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0093","doi-asserted-by":"crossref","first-page":"D344","DOI":"10.1093\/nar\/gkaa977","article-title":"The InterPro protein families and domains database: 20 years on","volume":"49","author":"Blum","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2021.08.001_bib0094","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/jhg.2017.15","article-title":"Clinical diversity caused by novel IGHMBP2 variants","volume":"62","author":"Yuan","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejmg.2018.04.001","article-title":"An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1)","volume":"61","author":"Wu","year":"2018","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.nmd.2021.08.001_bib0096","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ppul.21419","article-title":"Noisy breathing and hemidiaphragm paralysis progressing to respiratory failure in an infant","volume":"46","author":"Baughn","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0097","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1205","article-title":"Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients","volume":"8","author":"Tsang","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.nmd.2021.08.001_bib0098","article-title":"Diagnostic odyssey and application of targeted exome sequencing in the investigation of recurrent infant deaths in a Syrian consanguineous family: a case of spinal muscular atrophy with respiratory distress type 1","volume":"34","author":"Kim","year":"2019","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.nmd.2021.08.001_bib0099","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cga.12280","article-title":"Spinal muscular atrophy with respiratory distress type 1 associated with novel compound heterozygous mutations in IGHMBP2: differential diagnosis in a case with congenital diaphragm eventration","volume":"59","author":"Yasui","year":"2019","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.nmd.2021.08.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.676","article-title":"Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-Tooth phenotype with early onset symptoms","volume":"7","author":"Cassini","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.nmd.2021.08.001_bib0101","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X18769811","article-title":"Spinal muscular atrophy with respiratory distress type 1\u2014a child with atypical presentation","volume":"5","author":"Chiu","year":"2018","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.nmd.2021.08.001_bib0102","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0883073813477203","article-title":"One novel and one recurrent mutation in IGHMBP2 gene, causing severe spinal muscular atrophy respiratory distress 1 with onset soon after birth","volume":"29","author":"Litvinenko","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0103","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.nmd.2011.02.005","article-title":"Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man","volume":"21","author":"Pierson","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0104","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejpn.2011.10.005","article-title":"Infantile spinal muscular atrophy with respiratory distress type i (SMARD 1): an atypical phenotype and review of the literature","volume":"16","author":"Messina","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0030-1262852","article-title":"A new nonsense mutation of the IGHMBP2 gene responsible for the first case of SMARD1 in a sardinian patient with giant cell hepatitis","volume":"41","author":"Fanos","year":"2010","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2021.08.001_bib0106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nmd.2008.11.013","article-title":"Interfamilial phenotypic heterogeneity in SMARD1","volume":"19","author":"Joseph","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.08.001_bib0107","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/0972-2327.168635","article-title":"Spinal muscular atrophy with respiratory distress syndrome (SMARD1): case report and review of literature","volume":"19","author":"Lingappa","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.nmd.2021.08.001_bib0108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nmd.2013.11.013","article-title":"Early infantile sensory-motor neuropathy with late onset respiratory distress","volume":"24","author":"Blaschek","year":"2014","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621005861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621005861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:41Z","timestamp":1760775101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621005861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0960896621005861"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.08.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models for IGHMBP2-associated diseases: an overview and a roadmap for the future","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}